BLACK WEEKSViales −15% · kits −10% · resto −5%con el códigoEnvío gratis en Alemania a partir de 200 €

Esta página se ha traducido automáticamente y puede contener errores. ¿Eres hablante nativo? Nos encantaría recibir tus comentarios y correcciones.Enviar comentarios

The Peptide Desk The Peptide Desk
Retatrutide, foto del producto

7 informes de laboratorio

PDF
99%
Pureza
Analizado
Retatrutide 10mg
Laboratorio
Analiza Białek
Fecha
November 2026
Resultado
99% purity (10.37 mg measured)
Endotoxinas
5.54 EU/vial
N.º de pedido
Contraseña

Analizado de forma independiente, verificable con la contraseña directamente en el laboratorio.

GLP-1

Retatrutide

GLP-1

Pedido

Precio unitario - Envío gratis en Alemania a partir de 200 € durante las Black Weeks
  • DHL con seguimiento
  • Embalaje discreto

4.6 de 5 en Trustpilot73 reseñas

También buscado como: Retatrutid · Reta · LY3437943

De un vistazo

Retatrutide en cifras

Las cifras clave de nuestra enciclopedia. Arrastra el punto a lo largo de la curva para ver cuánto queda tras una dosis, según el cálculo.

Entrada completa de la enciclopedia

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~6 days

Half-life ~6 days
After 12 days: 25 %
Day 650 %Day 7, next dose45 %Day 1225 %Day 1812.5 %Day 303.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

~6days

Class
Triple agonistGLP-1 / GIP / glucagon
Frequency
Once weeklysubcutaneous
Form
Lyophilised powderreconstituted with BAC water
Sizes
5 to 60 mg11 sizes in the shop

Conocimiento

Todo sobre Retatrutide

Información detallada próximamente.

Conviene tenerlo

Lo que necesitas con ello

El agua bacteriostática se añade automáticamente a tu carrito. Jeringas y toallitas con un clic.

Jeringas de insulina

10 uds. · 5.50 €

Toallitas con alcohol

50 uds. · 10 €

¿Cuánta agua?

Unidades en la jeringa para tu tamaño de vial.

Abrir calculadora →

FAQ

Preguntas frecuentes

Fuentes de cada respuesta: entrada de la enciclopedia

¿Aún tienes alguna pregunta?

Escríbenos, nuestro equipo te ayudará.

Is Retatrutide approved?

No, as of 25 October 2026 there is no approval. Retatrutide is in phase 3: 14 phase 3 trials are listed on ClinicalTrials.gov, five of them completed. The first phase 3 results were published in 2026.

How does Retatrutide differ from Tirzepatide and Semaglutide?

The number of receptors. Semaglutide acts only on the GLP-1 receptor, Tirzepatide on GLP-1 and GIP. Retatrutide also targets the glucagon receptor. In animal models this added higher energy expenditure. A head-to-head trial against Tirzepatide is still running (TRIUMPH-5).

What did the phase 3 trials show?

In TRIUMPH-1 (obesity without diabetes) weight fell by 25.0 percent on average after 80 weeks at the highest study dose, by 3.9 percent on placebo. In TRIUMPH-2 (with type 2 diabetes) it was 18.8 versus 5.1 percent. In TRANSCEND-T2D-1 long-term blood sugar (HbA1c) fell by up to 1.94 percentage points in 40 weeks.

What happens to liver fat?

In a substudy with fatty liver (MASLD) liver fat fell by about 81 to 82 percent after 24 weeks in the two higher levels. 86 percent reached normal liver fat below 5 percent at the highest level. A large phase 3 trial on liver disease runs until 2030.

Which side effects were seen?

Most often gastrointestinal effects such as nausea and diarrhoea, depending on the dose. In TRIUMPH-2 abnormal skin sensations (dysaesthesia) and low blood pressure occurred more often than on placebo. In the phase 2 trial heart rate rose in a dose-dependent way, most around week 24.

Which trials are still running?

Nine phase 3 trials are not finished yet. The largest: TRIUMPH-OUTCOMES on heart and kidney events with about 10,000 participants (planned end 2029) and SYNERGY-Outcomes on fatty liver (2030). The comparison with Tirzepatide (TRIUMPH-5) is due to reach its primary endpoint in November 2026.

Comparativas

Cómo se compara

Relacionados

Productos relacionados